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Received 19 November 2009; received in revised form 3 March 2010; accepted 18 March 2010Abstract Mesenchymal stem cells (MSC) have been isolated from almost every adult tissue. In cord blood (CB), different non-
hematopoietic CD45-, CD34− adherent cell populations can be generated: the cord blood derived MSC (CB-MSC), that
behave almost like MSC from bone marrow (BM-MSC), and unrestricted somatic stem cells (USSC) which show a distinct
differentiation potential into all three germ layers. However, distinguishing these populations easily by molecular markers is
still a concern. In this study we were able to present the HOX expression pattern of USSC, CB-MSC and BM-MSC, which in fact
allows a discrimination of these populations.
Briefly, RT-PCR analysis of the HOX code revealed a high similarity between BM-MSC and CB-MSC, which are both HOX-positive,
whereas USSC resembled H9 embryonic stem cells HOX-negative.Especially HOXA9, HOXB7, HOXC10 and HOXD8 are
good candidate markers to discriminate MSC from USSC. Thus, our data suggest that the "biological fingerprint" based
on the HOX code can be used to distinguish functionally distinct MSC populations derived from bone marrow and
cord blood.
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41HOX code as biological fingerprintIntroduction
The presence of primitive non-hematopoietic stem/progen-
itor cells in cord blood was reported by our group (Kogler
et al., 2005) and confirmed by others (Chan et al., 2007;
Chang et al., 2006; Kern et al., 2006; Kim et al., 2005). In our
lab, characterization of unrestricted somatic stem cells
(USSC) from CB that have unique proliferation capacities and
can be differentiated in vitro into mesodermal, endodermal
and ectodermal lineages was performed (Greschat et al.,
2008; Sensken et al., 2007; Kogler et al., 2004; Trapp et al.,
2008). Although USSC possess several overlapping features
with MSC derived from CB or from bone marrow (BM), such
as immunophenotype, osteogenic and chondrogenic in vitro
and in vivo differentiation potential, USSC differ from BM-
MSC with regard to their immunological behavior (van den
Berk et al., 2009; Winter et al., 2008) and their neural
differentiation potential (Greschat et al., 2008; Kogler
et al., 2004). MSC can be differentiated into osteoblasts,
adipocytes or chondrocytes in culture or in vivo (Prockop,
1997; Prockop et al., 2003). Over the last years a char-
acterization of a large number of CB-derived cell lines in
terms of their adipogenic, neural and endodermal differen-
tiation potential was achieved. Based on these results, a
classification of CB-derived cell lines regarding their adipo-
genic differentiation potential was suggested (Kogler et al.,
2009). In an actual work by Jansen et al., functional
differences between USSC, BM-MSC and AdAS were analyzed
on global transcriptome level and several differentially
expressed genes were defined (Jansen et al., 2009), but
markers capable of distinguishing between USSC and CB-
MSC are still lacking. Therefore, several questions were
addressed here: Which possible molecular markers can
distinguish between USSC and CB-MSC derived from cord
blood, and what kind of impact could these markers have on
biological functions or transplantation.
Homeobox genes encode homeodomain-containing tran-
scription factors determining the positional identity along
the anterior-posterior body axis of animal embryos (Krum-
lauf, 1994). In humans, the 39 known HOX genes are
distributed among four clusters HOXA to HOXD, located in
chromosomes 7, 17, 12 and 2, respectively. HOX genes are
expressed sequentially 3´ to 5´ along the anterior-posterior
axis during embryogenesis, termed “temporal and spacial
colinearity” (Kmita and Duboule, 2003). The typical HOX
code of a cell describes the specific expression of function-
ally active HOX genes in distinct tissues (Kessel and Gruss,
1991). Recent findings revealed that this intrinsic HOX code
of a cell reflects a continuation of embryonic patterning
(Morgan, 2006), and several studies have reported on specific
HOX gene expression in adult human tissues (Yamamoto
et al., 2003; Takahashi et al., 2004). Ackema et al. recently
described in mice that mesenchymal stroma cells from
different organs are characterized by distinct topographic
HOX codes (Ackema and Charite, 2008). Ackema et al.
reported that even if there is a broad similarity of all MSC
tested, these can be subdivided by their specific topographic
HOX code depending on the tissue of origin. Another study by
Chang et al. revealed that fibroblasts from different
anatomic sites across the human body express distinct HOX
patterns (Chang et al., 2002). In addition Chang et al.
presented data that more than 1000 genes are differentiallyexpressed due to the anatomical origin of the cell. Others
were able to confirm in mice that the typical HOX code can
be sufficient to indicate the positional identity of a cell and
that the position-specific HOX code is independent of the age
of the donor (Rinn et al., 2006, 2008). In an actual work by
Hwang et al., HOXC10 was defined as a potential marker for
discriminating between human amnion- and decidua-derived
mesenchymal stem cells (Hwang et al., 2009).
However, analyzing HOX expression patterns in different
cell types seems to be useful to clarify the cell origin and
subdivide similar cell types, like mesenchymal stem, cells
regarding their tissue of origin. Thus an expression analysis of
all 39 known human HOX genes in functionally distinct
adherent non-hematopoietic cell populations derived from
cord blood was performed and possible markers to distin-
guish between them were defined in this study.Results
Analysis of Affymetrix chips revealed HOX genes as
potential molecular markers to distinguish between
USSC and CB-MSC
The primary basis of this work was a DNA-array (Affymetrix)
including in total 5 CB-derived cell lines (USSC n=3; CB-MSC
n=2). To first assess relatedness between the CB-derived
stem cell populations, a principal component analysis (PCA)
was performed. As depicted in Fig. 1, the two independent
samples of CB-MSC (red) grouped together, while the three
USSC samples (blue) are more divergent but in one plane.
The divergency between the cell populations reflects the
biological heterogeneity of the samples. These already
preliminary data indicate that two different populations
exist in cord blood, which can be distinguished by their
diffentiation potential (Kogler et al., 2009). Further analysis
revealed 271 probesets, which are significantly differentially
expressed between UCCS and CB-MSC. Of these, 158
probesets were upregulated and 113 probesets were down-
regulated in USSC. Subsequently, the Affymetrix Ids,
according to the 271 differentially expressed probesets,
were subjected to a Functional Annotation Chart analysis
offered by the DAVID Bioinformatics Resources 2008 home-
page (http://www.david.abcc.ncifcrf.gov/) (Dennis et al.,
2003; Sherman et al., 2007; Huang da et al., 2009). The
results of this analysis are shown in Table 1. Chart Report is
an annotation-term-focused view, which lists annotation
terms and their associated genes under study. This tool is
useful to discover enriched functional-related gene groups.
Analysis outcome revealed that the detected GO terms are
mainly functionally related to transcription factors and
developmental processes. Checking the detailed gene lists
of the top 10 GO terms, it was found that the first 6
functional groups comprise 17 HOX genes, a list of which is
presented in the supplement Table S2. Consequently, an
analysis of the expression data of all 39 HOX genes in USSC
and CB-MSC followed and all hits belonging to HOX genes
from the Affymetrix chips were extracted. Fig. 2 depicts the
relative expression values taken from the Affymetrix chip of
all 39 HOX genes. The values from USSC (n=3) and CB-MSC
(n=2) were compared to each other. Again, USSC revealed
almost no expression of HOX genes, whereas CB-MSC cell
Figure 1 Principal Component Analysis (PCA) of global gene expression profile of USSC and CB MSC. Red: CB-MSC, blue: USSC.
Principal Component Analysis (PCA)/ calculates the PCA scores and visually represents them in a 3D scatter plot. The first, second and
third principal component (PC) capture the sample populations´ variability respectively. The first PC separates maximally between
CB-MSC and USSC. The second and third PC separates the biological variabilities within the two different populations.
42 S. Liedtke et al.lines showed high expression of numerous HOX genes of each
cluster. The most prominent ones in CB-MSC are HOXA9,
HOXA10, HOXB2, HOXB7, HOXC6, HOXC10 and HOXD8.
HOXC6 and HOXC10 reached the highest expression with
relative expression values at 7000 (HOXC10) and 10000Table 1 Functional Annotation Chart
Term Cou
GO:0043565∼ sequence-specific DNA binding 24
GO:00 03700∼transcription factor activity 31
GO:0007275∼multicellular organismal development 54
GO:0032502∼developmental process 64
GO:0030528∼ transcription regulator activity 33
GO:0032501∼multicellular organismal process 64
GO:0009653∼anatomical structure morphogenesis 29
GO:0048856-∼anatomical structure development 44
GO:0009887∼organ morphogenesis 15
GO:0001501∼skeletal development 11
271 probeset IDs that were found to be significantly differentially exp
Functional Annotation Chart Tool to identify GO terms with unbalanced
Affymetrix HG-U133_Plus_2 probeset list). The top 10 GO terms are sh(HOXC6). These preliminary results ascertain that the
“biological fingerprint” of a specific cell type is reflected
by a typical HOX code, and, as a consequence thereof, the
HOX code can be used as a molecular marker to discriminate
USSC from CB-MSC.nt % PVaIue Benjamini
10,48% 6,27E-09 1,80 E-05
13,54% 1,12E-07 1,61 E-04
23,58% 6,16E-07 0,003227888
27,95% 8,57E-06 0,022260891
14,41% 6,09E-05 0,056751315
27,95% 3,95E-05 0,066772989
12,66% I,09E-04 0,133539358
19,21% 2,33E-04 0,217104075
6,55% 4,63E-04 0,293219656
4,80% 4,14E-04 0,304147747
ressed by USSC and CB MSC were further analyzed by the DAVID
distribution of this query list compared to a background list (here:
own.
Figure 2 Comparison of relative mRNA expression levels of 39 HOX genes in USSC and CB-MSC determined by careful data analysis of
our Affymetrix HG-U133_Plus_2 expression arrays. Relative expression values are shown for HOX Cluster A (A), B (B), C (C) and D (D). If
more than one probeset was used in the array, mean values are depicted in the graph. Raw data is available in Table S1. The mRNA
steady state levels are represented for each sample of USSC (n=3) and CB-MSC (n=2).
43HOX code as biological fingerprintEpigenetic status of HOX genes in USSC in
comparison to ESC
In addition to the array data, the epigenetic status of the
HOX genes in USSC, CB-MSC and H9 embryonic stem cells was
determined. Especially USSC in comparison to H9 cells, which
preserve their pluripotency by repressing their HOX genes,
was assessed (Soshnikova and Duboule, 2008). Based on the
Affymetrix data it would be expected to see methylation
ranging over all 4 clusters, which would explain as a result
the lack of HOX gene expression in USSC and H9 cells. Roche
NimbleGen provides sensitive and specific DNA methylation
microarrays that allow a precise identification of methylated
DNA regions across whole genomes or within biologically
focused regions including promoters and CpG islands (Mohn
et al., 2008; Weber et al., 2007; Zilberman et al., 2007;
Rauch et al., 2007; Yasui et al., 2007). The DNA methylation
analysis of all four HOX clusters is depicted in Fig. 3. The
methylation status of H9 embryonic stem cells in comparison
to USSC is very similar and corresponds to the expression data
deriving from affymetrix chips (Table S3). Except for some
cases, the peaks reflecting the methylation status of the
genomic region is comparable between H9 embryonal stem
cells and USSC. The HOXA cluster is highly methylated in all
populations. The CB-MSC seem to be higher methylated as
compared to USSC, which would not be expected by the
affymetrix data, because many of the HOXA genes are
detectable. The methylation of the HOXA cluster is signif-
icantly lower in USSC as compared to H9. Nevertheless,based on affymetrix data, transcription of the HOXA genes is
rarely detectable in USSC and H9. The clusters B-D are less
methylated in all three populations and would allow, in some
cases, an expression of several HOX genes. This might explain
why CB-MSC seem to express several HOX genes of all four
clusters based on the affymetrix data whereas USSC and H9
do not. Still, non-methylated parts within the HOX gene
cluster do not directly refer to transcription with respect to
other regulative mechanisms of transcription, like posttran-
scriptional regulation by splicing, or posttranslational by
modification and ubiquitinilation. Due to the fact that the
epigenetic analysis can only serve as a prediction for the
possible expression of genes, RT-PCR analysis is mandatory
to define putative markers in order to distinguish USSC from
CB-MSC.Determination of specific HOX expression pattern
by RT-PCR
To validate the preliminary array data, primers specific for
each HOX gene (Table S1) were designed. The expression of
each known HOX gene was detected by RT-PCR (Table 2).
This analysis included USSC cell lines (n=7), CB-MSC cell lines
(n=7) and BM-MSC cell lines (n=7) to show the differences
between these populations. In addition, several common
cell lines like HEK, Hela, NHDF, H9 and nTERA-2, as well
as adipose tissue-derived MSC and some distinct tissues
like femoral muscle, brain and liver, were analyzed. After
Figure 3 DNAmethylation analysis of the 4 HOX loci by NimbleGen. A global overview of the DNAmethylation status of the HOX gene
clusters A, B, C and D of USSC, CB-MSC and H9 ES cells is given. Grey boxes display the localization of the HOX genes within the cluster.
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45HOX code as biological fingerprintvisualization on agarose gels, the band intensity was defined
either as negative -, weakly expressed (-) or as one of three
levels positively expressed (+, ++ and +++). The RT-PCR
results revealed that BM-MSC samples as well as CB-MSC
samples share a high homology regarding their HOX code.
With the exception of the CB-MSC samples 4, 5 and 7, which
express fewer HOX genes in comparison to the other CB-MSC
samples. This can reflect biological variations, or one can
hypothesize that other MSC-like population are present in
cord blood. The most highly expressed HOX genes in BM-MSC
as well as in CB-MSC are HOXA5, 9 and 10, HOXB6 and 7,
HOXC4-10 and HOXD3-4, and 8. In both MSC populations, the
5´ positioned HOX genes are barely or not expressed in all
four HOX clusters. The 3´ HOX genes are mainly expressed in
Cluster A and C, while in Cluster D they show only partial
expression. In the HOXB cluster the expression of 3´ HOX
genes is almost absent. Further detailed examination of each
single HOX gene revealed HOXD9 as a putative distinguishing
feature between CB-MSC (HOXD9+) and BM-MSC (HOXD9-).
However, both MSC populations show quite a similar
expression pattern. Compared to both MSC populations,
USSC show almost no expression of HOX genes was detected.
Only in some cases a very low expression of different HOX
genes detected. The only gene we expected to be higly
expressed was HOXB2 based on the Affymetrix data (Fig. 2).
USSC line 2 revealed no expression of HOXB2 (Table S3).
Since only one probe was used in affymetrix (205453_at), and
taking into account the possible heterogeneity of this special
gene within the USSC populations, HOXB2 expression might
be not representative in USSC. However, after testing two
different primer pairs, RT-PCR analysis revealed expression of
HOXB2 only in adipose tissue derived MSC and HEK and never
in USSC showing that the primer pair used in this analysis
worked. The USSC share the HOX-negative expression pattern
with the embryonal cell line H9 and the embryonal terato-
carcinoma cell line nTERA-2. It is well documented that
embryonic stem cells preserve their pluripotency by repres-
sing their HOX genes (Soshnikova and Duboule, 2008). The
HOX-negative status of USSC therefore might reflect the
higher immaturity of this cell type in comparison to MSC and
could explain the distinct differentiation potential. Addition-
ally, further tissue samples were tested from femoral muscle,
brain and liver where muscle possessed a HOX-positive profile
and brain and liver a HOX-negative status.
In analogy to the Affymetrix data the most prominent
genes in CB-MSC are HOXA9, HOXA10, HOXB7, HOXC6,
HOXC10 and HOXD8.Definition of HOXA9, HOXB7, HOXC10 and HOXD8 as
molecular markers to distinguish USSC and CB-MSC
by quantitative RT-PCR
Although HOXA10 and HOXC6 revealed the highest expression
based on the Affymetrix data and the RT-PCRdata, these genes
were excluded from further analysis due to alternative splice
variants. The primers used in this experiment detect both
splice variants. The function of these splice variants has not
been elucidated yet in detail (Shimeld et al., 1993; Lawrence
et al., 1995; Benson et al., 1995), therefore HOXA9, HOXB7,
HOXC10 and HOXD8 were defined as good potential molecular
markers to discriminate between USSC and CB-MSC.In a simple RT-PCR approach, 20 different cell lines
derived from cord blood and 3 different BM-MSC lines were
tested (data not shown). Of the 20 CB-derived cell lines
tested, 3 were classified as CB-MSC and 17 as USSC cell lines
based on their adipogenic differentiation potential, which is
tested routinely in our lab as quality control (Kogler et al.,
2009) (Fig. S1). Based on the 4 HOX genes tested, it was
possible to confirm that USSC as well as embryonic stem cells
are negative for the 4 HOXmarkers tested, whereas BM-MSC,
CB-MSC and highly differentiated adipose tissue-derived MSC
are positive for these markers. Hence the differentiation
potential of cell lines derived from cord blood can be linked
to the expression of the HOX genes. Moreover, testing the 4
molecular HOX markers facilitates the characterization of
cord blood derived cell lines in comparison to the time
consuming determination of the differentiation potential
(Sensken et al., 2007; Kogler et al., 2004, 2009).
In a next step the data was confirmed in a quantitative real
time PCR approach. As a negative control the embryonal
teratocarcinoma cell line nTERA-2 was employed, which was
negative forHOX gene expression in the RT-PCR approach. The
positive control was the HEK cell line, known to be positive for
the majority of HOX genes. All samples applied here were
normalized to the HEK cell line. Fig. 4 depicts the results of the
quantitative PCR. Comparison of the expression values of each
cell type tested showed that USSC cell lines are HOX-negative
on quantitative level, confirming the preliminary RT-PCR
results. By comparison, CB-MSC and BM-MSC expressed many
HOX genes. HOXC10 reached the highest expression of all
markers tested, in fact expressing 7-30 fold more as compared
to the HEK cell line. By contrast, HOXA9, HOXB7 and HOXD8
achieved moderate levels of gene expression, comparable to
the positive control. Nevertheless, evaluating the gene
expression of the four markers tested on quantitative level
definitively confirmed the potential of the HOX markers to
distinguish CB-MSC from USSC.Discussion
MSC populations can be isolated from numerous human
tissues (Kogler et al., 2004; Zuk et al., 2001; Goodwin et al.,
2001), but the relatedness of these cells remains largely
unknown. Cord blood is currently used as an alternative to
bone marrow as a source of stem cells for hematopoietic
reconstitution after ablation. It is also under intense
preclinical investigation for a variety of indications ranging
from stroke, to limb ischemia, to myocardial regeneration
(Riordan et al., 2007; Hu et al., 2006; Brzoska et al., 2006;
Leor et al., 2006; Newcomb et al., 2006). Key questions
concerning the differences between cord blood-derived cell
populations regarding their origin, differentiation potential,
tumorigenicity, and availability still need to be answered
(Buchheiser et al., 2009). Over the last years, numerous CB-
derived cell lines were generated and characterized based
on their differentiation potential in our lab. Beyond the
biological small variations between the cell lines, it was
detected that adipogenic differentiation is present in CB-
MSC, but absent in USSC (Kogler et al., 2009). In order to
distinguish easily between these two populations derived
from cord blood, it is mandatory to define cell type-specific
markers. Here, we were able to present the HOX code as a
Table 2 Comprehensive RT-PCR based expression profiling of 39 HOX genes
46
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Figure 4 Representative expression patterns of the new putative marker genes HOXA9, HOXB7, HOXC10 and HOXD8. Differential
expression of the four HOX genes were verified by means of real-time PCR. Relative changes in gene expression were calculated using
the ΔΔCt-method with GAPDH as internal standard and normalized to human embryonic kidney (HEK) cells.
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MSC populations derived from cord blood. HOX gene
expression especially in BM-MSC, CB-MSC and USSC was
evaluated by RT-PCR. Several common cell lines like HEK,
Hela, NHDF, H9 and nTERA-2, as well as adipose tissue-
derived MSC and some distinct tissues like femoral muscle,
brain and liver were included in this study to complete the
analysis. Furthermore, HOXA9, HOXB7, HOXC10 and HOXD8
were defined as potential molecular markers, which are
highly differentially expressed in USSC and CB-MSC. In an
actual work by Jansen et al., functional differences between
USSC, BM-MSC and AdAS were analyzed on global transcrip-
tome level (Jansen et al., 2009). Within the top 25 genes that
are upregulated in BM-MSC compared to USSC, they found
HOXC10 four fold differentially expressed, which could also
be confirmed by the data provided here. In a recent work by
Hwang et al., HOXC10 was defined as a potential marker to
distinguish amnion- and decidua-derived mesenchymal stem
cells (Hwang et al., 2009). Our data are in agreement with
the findings of Hwang et al., therefore, determining the
function of HOXC10 in these cells is an interesting task for
future prospects. In addition, the determination of the
specific HOX codes revealed a high similarity between BM-
MSC and CB-MSC. These two cell populations could be
distinguished by only some HOX genes, namely HOXD9 and
HOXD10 as the most prominent ones in RT-PCR experiments.
Taken together with the results of the affymetrix chips
(Table S3) only HOXD9 is expressed in CB-MSC and is absent in
BM-MSC. Expression of many HOX genes was also present in
adipose tissue-derived MSC confirming the data by Lee et al.
(Lee et al., 2004), who described that the genetic expressionNotes to Table 2:
Band intensities were depicted with +++ for highly expressed, ++ for stro
not expressed. Abbreviations: a. (adult), f. (fetal), HEK (human embryon
marrow mesenchymal stem cells), CB-MSC (cord blood mesenchymal steprofiles of BM-MSC and adipose tissue-derived MSC is similar.
Whether this correlation reflects the ability of MSC to
differentiate into adipocytes remains elusive. The expres-
sion of HOX genes was mainly absent in USSC, H9 and nTERA-2
cells. In addition, brain and liver tissues were HOX-negative.
Taken together, we were able to document here that CB-MSC
resemble BM-MSC and that USSC are more similar to
embryonic stem cells based on their HOX code without
expressing the specific ES-cell markers Oct4, Sox2 and Nanog
(Kogler et al., 2009; Liedtke et al., 2007, 2008; Buchheiser
et al., 2008.
The aspect of the HOX-negative status is also an important
factor relevant for transplantation:
In a recent publication, interesting biological and func-
tional aspects of HOX genes were highlighted (Wang et al.,
2009). One is the influence of the HOX code in the process of
adult bone regeneration (Leucht et al., 2008) and wound
healing (Creuzet et al., 2002). In the work of Leucht et al.
it was documented that HOX-negative mandibular skeletal
progenitor cells adopt a HOX-positive profile when trans-
planted into a HOX-positive tibial defect. Conversely, HOX-
positive tibial skeletal progenitor cells maintain the HOX
status even when transplanted into a HOX-negative mandib-
ular defect (Leucht et al., 2008). In this context the HOX-
negative status of USSC in comparison to CB-MSC is im-
portant. In a no injury in utero sheep model it was shown that
USSC have the potential to differentiate into parenchymal
liver cells (Kogler et al., 2004). Our analysis revealed that
USSC as well as liver were HOX-negative. Taking into account
that HOX-negative stem or precursor cells can adopt the
HOX-positive status if they are transplanted in HOX-positivengly expressed, + for expressed, (-) for weakly expressed and – for
ic kidney), NHDF (normal human dermal fibroblasts), BM-MSC (bone
m cells), USSC (unrestricted somatic stem cells).
48 S. Liedtke et al.tissues but not vice versa (Leucht et al., 2008; Creuzet et al.,
2002), it can be hypothesized that USSC would have a higher
regenerative potential in comparison to CB-MSC or other MSC
derived from bone marrow. As reflected by their typical HOX
code, it can be speculated that matching the HOX code of the
transplanted stem cell with the host tissue is mandatory to
achieve engraftment and regenerative healing.
Currently,HOX gene expression has beenmainly focused on
embryonic patterning in drosophila (Akam, 1998). In the
murine and human system, the literature comprises a lot of
information about the association of HOX gene expression and
cancer development, but the identification of critical HOX
subsets and their functional role in cancer onset and
maintenance requires further investigation (McGonigle et
al., 2008). In some recent publications, the HOX code was
mainly used as a “biological fingerprint” of different cell types
(Ackema and Charite, 2008; Rinn et al., 2008; Hwang et al.,
2009). In 2004 Takahashi et al. (Takahashi et al., 2004)
presented expression profiles of HOX genes in human adult
organs and anaplastic thyroid cancer cell lines by quantitative
real-time RT-PCR. Their results showed that HOX genes are
organ-specifically expressed. However, as presented here, the
“biological fingerprint” can be applied to define functionally
distinct MSC populations derived from cord blood and other
tissues. Regarding the fact that cord blood stem cells are a
valuable source of neonatal cells, the definition of the HOX
status might be important for transplantations.
The 4 markers defined in this study are now used routinely
in our lab to prospectively define the cell lines generated.
We hope that our findings will support the idea that the
HOX code is the “biological fingerprint” of a cell useful to
determine and distinguish different cell types, and in the
case of adult stem cells as demonstrated here can provide
additional information about a putative regenerative poten-
tial important for transplantations.Materials & Methods
Generation and Expansion of CB-derived cells
USSC and CB-MSC were generated by the same method.
Classification of the adherent cells into USSC and CB-MSC was
only possible after generation by determining the adipogenic
differentiation potential (Fig. S1). CB was collected from
umbilical cord vein with informed consent of the mother.
MNC were obtained by ficoll (Biochrom, density 1.077 g/cm3)
gradient separation followed by ammonium chloride lysis of
RBCs. 5–7 106 CB MNC /ml were cultured in T75 culture flasks
(Corning) in DMEM low glucose (Cambrex) with 30% FCS
(Perbio), 10–7 M dexamethasone (Sigma-Aldrich), penicillin /
streptomycin and L-glutamine (PSG;Cambrex). When colo-
nies were detected, cells were expanded without dexa-
methasone in a closed system applying cell stacks (Corning).
Cord blood derived stem cells (USSC and CB-MSC) were
incubated at 37 °C in 5% CO2 in a humidified atmosphere.
Reaching 80% confluence, cells were detached with 0.25%
trypsin (Cambrex) and replated 1:3. Each cell line generated
was obtained from an individual cord blood sample since the
frequency of the cells is very low (Kogler et al., 2006).Total RNA extraction and Reverse Transcription
Total RNA was extracted from cell lines and cell samples in a
40 µl volume applying the Rneasy Kit (Qiagen) according to the
manufacturer's instructions. Determination of RNA concentra-
tionswas carried out by applying a Nanodrop device (NanoDrop
Technologies). Reverse transcription was performed for 1 h at
50 °C using the First-strand cDNA Synthesis Kit (Invitrogen) and
the enclosed oligo(dT)20 Primer. About 500 ng total RNA was
converted into first-strand cDNA in a 20 µl reaction. All control
reactions provided with this system were carried out to
monitor the efficiency of cDNA-synthesis. Prior to PCR, the
completed first-strand reaction was heat-inactivated at 85 °C
for at least 10 min. Finally, cDNA was treated with RNAseH
according to the manufacturer´s protocol.
RT-PCR and real time PCR
RT-PCR was carried out by designing intron-spanning primers
specific for each HOX gene (Thermo Scientific). GAPDH was
used as reference gene for normalization in all experiments.
Approximately 15 ng of cDNA was used for subsequent RT-
PCR-analysis in a total volume of 25 µl containing 1x PCR-
buffer, 0.2 µM of each primer, 1.5 mM MgCl2, 0.2 mM each
dNTP and 1 U Taq DNA Polymerase (Invitrogen) at the
following conditions: (1) 2 min at 95 °C for initial Denatur-
ation and Taq Polymerase activation, (2) 30 sec at 95 °C,
30 sec at 56 °C, (3) 30 sec at 72 °C for 35 cycles, 5 min at
72 °C for final extension of PCR products. PCR was performed
on a Mastercycler ep gradient S (Eppendorf). Subsequently,
aliquots of the RT-PCR products and related controls were
analyzed on 2% agarose gel electrophoresis.
Real time PCR was carried out with SYBR® Green PCR
Mastermix (Applied Biosystems) using 50 ng template cDNA. All
reactionswere run in duplicates/triplicates, respectively, on an
ABI 7700 Detection System (Applied Biosystems). The sequences
for the primers were carefully examined and checked for their
specificity (a list of primers used is shown in the supplementary
data (Table S1)). Evaluation of Taq Man Gene Expression Assays
(Applied Biosystems) was performed with the SDS 2.3 software.
Relative changes in gene expression were calculated following
the ΔΔCt-method with glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) as internal standard and normalized to human
embryonic kidney (HEK) cells. Relative gene expression was
illustrated as mean values.
Analysis of microarrays
Cell lines used for affymetrix chips were cultured for 4 days.
On day 4 RNA was extracted according to the Rneasy Kit
protocol (Qiagen). Approx. 5 µg of total RNA of each
preparation were converted into labeled cRNA according to
the manufacturer´s Expression manual Version 2 (Affyme-
trix, Santa Clara CA, USA). Aliquots of the labelled and
subsequently fragmented cRNA were hybridized to Gene-
Chip® HG-U133_Plus_2 microarrays (Affymetrix, Santa Clara
CA, USA). Following several washing steps the hybridized
microarrays were scanned on a GC Scanner 3000 with G7
update. Digitized signal intensities were determined and raw
data quality was independently evaluated. The data were
further analyzed using Genespring 10.1 Software (Agilent).
49HOX code as biological fingerprintProbesets were filtered for fold-changes of ≥2.0 between
groups (USSC vs. CB-MSC) and significant regulations were
identified by an unpaired T-test with FDR-correction for
multiple testing (Benjamini-Hochberg, α=10%).
Annotation
Lists containing the differentially expressed probeset IDs
were subjected to the “Functional Annotation Chart Tool”
provided by DAVID Bioinformatics Resources (http://www.
david.abcc.ncifcrf.gov/) (Dennis et al., 2003; Sherman et al.,
2007; Huang da et al., 2009).
DNA methylation analysis by NimbleGen
1 µg genomic DNA from each cell line, the USSC, CB-MSC and
the ES cell line were sonicated to 300-1000 fragment size by
the Vibra Cell 75022 Ultrasonic Processor. These DNA sam-
ples then underwent immunoprecipitation of methylated
DNA employing the Diagenode´s MeDIP kit in accordance to
manufacturer´s instructions. Amplification of input and out-
put samples occurred applying the Genome Plex® Complete
WGA Kit ( Sigma Aldrich ) as described in the user´s guide.
Hybridization of 1 µg of each amplified DNA sample was
performed on NimbleGen 385 K RefSeq Promoter Arrays
HG18 containing all known RefSeq genes (Roche). The pro-
moter regions on these arrays are covered by 50-mer probes
with approximately 100 bp spacing. The hybridization pro-
cedure was applied as suggested by the manufacturer. The
hybridized arrays were scanned on an Axon 4000B microarray
scanner (Molecular Devices, Sunnyvale CA), and the images
were analyzed with Axon GenePix software version 4.1.
Image and data analyses were done by NimbleScan version
2.5 and SignalMap version 1.9 software.
Acknowledgments
First of all, we would like to thank Maria Kluth, Stefanie
Geyh and Foued Ghanjati for their excellent technical
support. We are grateful to Oliver Brüstle for generously
providing H9 RNA, and to Paolo Bianco and Hans Werner
Müller for helpful discussions. The work was supported by
the Deutsche Forschungsgemeinschaft (DFG) project
Ko2119/6-1 and the José Carreras Leukemia Foundation
grant DJCLS-R07/05v.
Appendix A. Supplementary data
Supplementary data associatedwith this article can be found,
in the online version, at doi:10.1016/j.scr.2010.03.004.
References
Ackema, K.B., Charite, J., 2008. Mesenchymal stem cells from
different organs are characterized by distinct topographic Hox
codes. Stem Cells Dev. 17, 979–991.
Akam, M., 1998. Hox genes: from master genes to micromanagers.
Curr. Biol. 8, R676–R678.
Benson, G.V., Nguyen, T.H., Maas, R.L., 1995. The expression
pattern of the murine Hoxa-10 gene and the sequence recogni-tion of its homeodomain reveal specific properties of Abdominal
B-like genes. Mol. Cell. Biol. 15, 1591–1601.
Brzoska, E., Grabowska, I., Hoser, G., Streminska, W., Wasilewska,
D., Machaj, E.K., Pojda, Z., Moraczewski, J., Kawiak, J., 2006.
Participation of stem cells from human cord blood in skeletal
muscle regeneration of SCID mice. Exp. Hematol. 34, 1262–1270.
Buchheiser, A., Liedtke, S., Houben, A.P., Waclawczyk, S., Stephan,
M., Radke, T.F., Wernet, P., Koegler, G., 2008. Cord Blood as a
Very Valuable Source of Neonatal Cells but Embryonic-Like
Nature Reevaluated. Blood 112, 997 abstract.
Buchheiser, A., Liedtke, S., Looijenga, L.H., Kogler, G., 2009. Cord
blood for tissue regeneration. J. Cell. Biochem. 108, 762–768.
Chan, S.L., Choi, M., Wnendt, S., Kraus, M., Teng, E., Leong, H.F.,
Merchav, S., 2007. Enhanced in vivo homing of uncultured and
selectively amplified cord blood CD34+ cells by cotransplantation
with cord blood-derived unrestricted somatic stem cells. Stem
Cells 25, 529–536.
Chang, H.Y., Chi, J.T., Dudoit, S., Bondre, C., van de Rijn, M.,
Botstein, D., Brown, P.O., 2002. Diversity, topographic differen-
tiation, and positional memory in human fibroblasts. Proc. Natl.
Acad. Sci. U. S. A. 99, 12877–12882.
Chang, Y.J., Shih, D.T., Tseng, C.P., Hsieh, T.B., Lee, D.C., Hwang,
S.M., 2006. Disparate mesenchyme-lineage tendencies in mes-
enchymal stem cells from human bonemarrow and umbilical cord
blood. Stem Cells 24, 679–685.
Creuzet, S., Couly, G., Vincent, C., Le Douarin, N.M., 2002. Negative
effect of Hox gene expression on the development of the neural
crest-derived facial skeleton. Development 129, 4301–4313.
Dennis Jr., G., Sherman, B.T., Hosack, D.A., Yang, J., Gao, W., Lane,
H.C., Lempicki, R.A., 2003. DAVID: Database for Annotation,
Visualization, and Integrated Discovery. Genome Biol. 4, P3.
Goodwin, H.S., Bicknese, A.R., Chien, S.N., Bogucki, B.D., Quinn, C.O.,
Wall, D.A., 2001. Multilineage differentiation activity by cells
isolated from umbilical cord blood: expression of bone, fat, and
neural markers. Biol. Blood Marrow Transplant. 7, 581–588.
Greschat, S., Schira, J., Kury, P., Rosenbaum, C., de Souza Silva, M.A.,
Kogler, G., Wernet, P., Muller, H.W., 2008. Unrestricted somatic
stem cells from human umbilical cord blood can be differentiated
into neurons with a dopaminergic phenotype. Stem Cells Dev. 17,
221–232.
Hu, C.H., Wu, G.F., Wang, X.Q., Yang, Y.H., Du, Z.M., He, X.H., Xiang,
P., 2006. Transplanted human umbilical cord blood mononuclear
cells improve left ventricular function through angiogenesis in
myocardial infarction. Chin. Med. J. (Engl). 119, 1499–1506.
Huang da, W., 2009. Systematic and integrative analysis of large gene
lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57.
Hwang, J.H., Seok, O.S., Song, H.R., Jo, J.Y., Lee, J.K., 2009.
HOXC10 as a Potential Marker for Discriminating between
Amnion- and Decidua-Derived Mesenchymal Stem Cells. Cloning
Stem Cells. 11, 269–279.
Jansen, B.J., Gilissen, C., Roelofs, H., Schaap-Oziemlak, A., Veltman,
J., Raymakers, R.A., Jansen, J., Kogler, G., Figdor, C.G.,
Torensma, R., Adema, G.J., 2009. Functional Differences between
Mesenchymal Stem Cell Populations Are Reflected by Their
Transcriptome. Stem Cells Dev.
Kern, S., Eichler, H., Stoeve, J., Kluter, H., Bieback, K., 2006.
Comparative analysis of mesenchymal stem cells from bonemarrow,
umbilical cord blood, or adipose tissue. Stem Cells 24, 1294–1301.
Kessel, M., Gruss, P., 1991. Homeotic transformations of murine
vertebrae and concomitant alteration of Hox codes induced by
retinoic acid. Cell 67, 89–104.
Kim, B.O., Tian, H., Prasongsukarn, K., Wu, J., Angoulvant, D.,
Wnendt, S., Muhs, A., Spitkovsky, D., Li, R.K., 2005. Cell
transplantation improves ventricular function after a myocardial
infarction: a preclinical study of human unrestricted somatic
stem cells in a porcine model. Circulation 112, I96–I104.
Kmita, M., Duboule, D., 2003. Organizing axes in time and space;
25 years of colinear tinkering. Science 301, 331–333.
50 S. Liedtke et al.Kogler, G., Sensken, S., Airey, J.A., Trapp, T., Muschen, M., Feldhahn,
N., Liedtke, S., Sorg, R.V., Fischer, J., Rosenbaum, C., Greschat,
S., Knipper, A., Bender, J., Degistirici, O., Gao, J., Caplan, A.I.,
Colletti, E.J., Almeida-Porada, G., Muller, H.W., Zanjani, E.,
Wernet, P., 2004. A new human somatic stem cell from placental
cord blood with intrinsic pluripotent differentiation potential.
J. Exp. Med. 200, 123–135.
Kogler, G., Radke, T.F., Lefort, A., Sensken, S., Fischer, J., Sorg, R.V.,
Wernet, P., 2005. Cytokine production and hematopoiesis support-
ing activity of cord blood-derived unrestricted somatic stem cells.
Exp. Hematol. 33, 573–583.
Kogler, G., Sensken, S., Wernet, P., 2006. Comparative generation
and characterization of pluripotent unrestricted somatic stem
cells with mesenchymal stem cells from human cord blood. Exp.
Hematol. 34, 1589–1595.
Kogler, G., Critser, P., Trapp, T., Yoder, M., 2009. Future of cord blood
for non-oncology uses. Bone Marrow Transplant. 44, 683–697.
Krumlauf, R., 1994. Hox genes in vertebrate development. Cell 78,
191–201.
Lawrence,H.J., Sauvageau,G., Ahmadi, N., Lopez, A.R., LeBeau,M.M.,
Link, M., Humphries, K., Largman, C., 1995. Stage- and lineage-
specific expression of the HOXA10 homeobox gene in normal and
leukemic hematopoietic cells. Exp. Hematol. 23, 1160–1166.
Lee, R.H., Kim, B., Choi, I., Kim, H., Choi, H.S., Suh, K., Bae, Y.C.,
Jung, J.S., 2004. Characterization and expression analysis of
mesenchymal stem cells from human bone marrow and adipose
tissue. Cell. Physiol. Biochem. 14, 311–324.
Leor, J., Guetta, E., Feinberg, M.S., Galski, H., Bar, I., Holbova, R.,
Miller, L., Zarin, P., Castel, D., Barbash, I.M., Nagler, A., 2006.
Human umbilical cord blood-derived CD133+ cells enhance function
and repair of the infarcted myocardium. Stem Cells 24, 772–780.
Leucht, P., Kim, J.B., Amasha, R., James, A.W., Girod, S., Helms, J.A.,
2008. Embryonic origin andHox status determineprogenitor cell fate
during adult bone regeneration. Development 135, 2845–2854.
Liedtke, S., Enczmann, J., Waclawczyk, S., Wernet, P., Kogler, G.,
2007. Oct4 and its pseudogenes confuse stem cell research. Cell
Stem Cell 1, 364–366.
Liedtke, S., Stephan, M., Kogler, G., 2008. Oct4 expression revisited:
potential pitfalls for data misinterpretation in stem cell research.
Biol. Chem. 389, 845–850.
McGonigle, G.J., Lappin, T.R., Thompson, A., 2008. Grappling with
the HOX network in hematopoiesis and leukemia. Front Biosci.
13, 4297–4308.
Mohn, F., Weber, M., Rebhan, M., Roloff, T.C., Richter, J., Stadler,
M.B., Bibel, M., Schubeler, D., 2008. Lineage-specific polycomb
targets and de novo DNA methylation define restriction and
potential of neuronal progenitors. Mol. Cell 30, 755–766.
Morgan, R., 2006. Hox genes: a continuation of embryonic
patterning? Trends Genet. 22, 67–69.
Newcomb, J.D., Ajmo Jr., C.T., Sanberg, C.D., Sanberg, P.R.,
Pennypacker, K.R., Willing, A.E., 2006. Timing of cord blood
treatment after experimental stroke determines therapeutic
efficacy. Cell Transplant. 15, 213–223.
Prockop, D.J., 1997. Marrow stromal cells as stem cells for
nonhematopoietic tissues. Science 276, 71–74.
Prockop, D.J., Gregory, C.A., Spees, J.L., 2003. One strategy for cell
and gene therapy: harnessing the power of adult stem cells to
repair tissues. Proc. Natl. Acad. Sci. U. S. A. 100 (Suppl 1),
11917–11923.
Rauch, T., Wang, Z., Zhang, X., Zhong, X., Wu, X., Lau, S.K.,
Kernstine, K.H., Riggs, A.D., Pfeifer, G.P., 2007. Homeobox gene
methylation in lung cancer studied by genome-wide analysis with
a microarray-based methylated CpG island recovery assay. Proc.
Natl. Acad. Sci. U. S. A. 104, 5527–5532.
Rinn, J.L., Bondre, C., Gladstone, H.B., Brown, P.O., Chang, H.Y.,
2006. Anatomic demarcation by positional variation in fibroblast
gene expression programs. PLoS Genet. 2, e119.Rinn, J.L., Wang, J.K., Allen, N., Brugmann, S.A., Mikels, A.J., Liu, H.,
Ridky, T.W., Stadler, H.S., Nusse, R., Helms, J.A., Chang, H.Y.,
2008. A dermal HOX transcriptional program regulates site-specific
epidermal fate. Genes Dev. 22, 303–307.
Riordan, N.H., Chan, K., Marleau, A.M., Ichim, T.E., 2007. Cord blood
in regenerative medicine: do we need immune suppression?
J. Transl. Med. 5, 8.
Sensken, S., Waclawczyk, S., Knaupp, A.S., Trapp, T., Enczmann, J.,
Wernet, P., Kogler, G., 2007. In vitro differentiation of human
cord blood-derived unrestricted somatic stem cells towards an
endodermal pathway. Cytotherapy 9, 362–378.
Sherman, B.T., Huang da, W., Tan, Q., Guo, Y., Bour, S., Liu, D.,
Stephens, R., Baseler, M.W., Lane, H.C., Lempicki, R.A., 2007.
DAVID Knowledgebase: a gene-centered database integrating
heterogeneous gene annotation resources to facilitate high-
throughput gene functional analysis. BMC Bioinform. 8, 426.
Shimeld, S.M., Gaunt, S.J., Coletta, P.L., Geada, A.M., Sharpe, P.T.,
1993. Spatial localisationof transcripts of theHox-C6 gene. J. Anat.
183 (Pt 3), 515–523.
Soshnikova, N., Duboule, D., 2008. Epigenetic regulation of Hox gene
activation: the waltz of methyls. Bioessays 30, 199–202.
Takahashi, Y., Hamada, J., Murakawa, K., Takada, M., Tada, M.,
Nogami, I., Hayashi, N., Nakamori, S., Monden, M., Miyamoto,
M., Katoh, H., Moriuchi, T., 2004. Expression profiles of 39 HOX
genes in normal human adult organs and anaplastic thyroid
cancer cell lines by quantitative real-time RT-PCR system. Exp.
Cell Res. 293, 144–153.
Trapp, T., Kogler, G., El-Khattouti, A., Sorg, R.V., Besselmann, M.,
Focking, M., Buhrle, C.P., Trompeter, I., Fischer, J.C., Wernet, P.,
2008. Hepatocyte growth factor/c-MET axis-mediated tropism of
cord blood-derived unrestricted somatic stem cells for neuronal
injury. J. Biol. Chem. 283, 32244–32253.
van den Berk, L.C., Jansen, B.J., Siebers-Vermeulen, K.G., Netea,
M.G., Latuhihin, T., Bergevoet, S., Raymakers, R.A., Kogler, G.,
Figdor, C.C., Adema, G.J., Torensma, R., 2009. Toll-like receptor
triggering in cord bloodmesenchymal stem cells. J. Cell. Mol. Med.
Wang, K.C., Helms, J.A., Chang, H.Y., 2009. Regeneration, repair
and remembering identity: the three Rs of Hox gene expression.
Trends Cell Biol. 19, 268–275.
Weber, M., Hellmann, I., Stadler, M.B., Ramos, L., Paabo, S.,
Rebhan, M., Schubeler, D., 2007. Distribution, silencing potential
and evolutionary impact of promoter DNA methylation in the
human genome. Nat. Genet. 39, 457–466.
Winter, M., Wang, X.N., Daubener, W., Eyking, A., Rae, M., Dickinson,
A.M., Wernet, P., Kogler, G., Sorg, R.V., 2008. Suppression of
Cellular Immunity by Cord Blood-Derived Unrestricted Somatic
Stem Cells is Cytokine Dependent. J. Cell. Mol. Med.
Yamamoto, M., Takai, D., Yamamoto, F., 2003. Comprehensive
expression profiling of highly homologous 39 hox genes in 26
different human adult tissues by the modified systematic
multiplex RT-pCR method reveals tissue-specific expression
pattern that suggests an important role of chromosomal
structure in the regulation of hox gene expression in adult
tissues. Gene Expr. 11, 199–210.
Yasui, D.H., Peddada, S., Bieda, M.C., Vallero, R.O., Hogart, A.,
Nagarajan, R.P., Thatcher, K.N., Farnham, P.J., Lasalle, J.M.,
2007. Integrated epigenomic analyses of neuronal MeCP2 reveal a
role for long-range interaction with active genes. Proc. Natl.
Acad. Sci. U. S. A. 104, 19416–19421.
Zilberman, D., Gehring, M., Tran, R.K., Ballinger, T., Henikoff, S.,
2007. Genome-wide analysis of Arabidopsis thaliana DNA meth-
ylation uncovers an interdependence between methylation and
transcription. Nat. Genet. 39, 61–69.
Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J.,
Benhaim, P., Lorenz, H.P., Hedrick, M.H., 2001. Multilineage
cells from human adipose tissue: implications for cell-based
therapies. Tissue Eng. 7, 211–228.
